Difficulty: Medium
Average Score: 84%
Practice
Which of the following antipsychotic drugs has the high risk of potentially fatal agranulocytosis and risk of seizures at high doses?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Clozapine. Clozapine is associated with a high risk of potentially fatal agranulocytosis, which is a serious condition characterized by a dangerously low white blood cell count. Additionally, at high doses, Clozapine also carries a risk of seizures.
Haloperidol (A) is a first-generation antipsychotic that is not typically known for causing agranulocytosis or seizures at high doses. Risperidone (B) is a second-generation antipsychotic that does not have as high a risk of agranulocytosis or seizures compared to Clozapine. Chlorpromazine (D) is another first-generation antipsychotic that is not commonly associated with agranulocytosis or seizures at high doses.
Educationally, it is important to understand the side effect profiles of different antipsychotic medications to make informed treatment decisions. Clozapine is a highly effective medication for treatment-resistant schizophrenia, but its potential for severe side effects like agranulocytosis necessitates close monitoring and careful consideration before prescribing. This knowledge is crucial for healthcare professionals to provide safe and effective care to patients with psychiatric disorders.
Haloperidol (A) is a first-generation antipsychotic that is not typically known for causing agranulocytosis or seizures at high doses. Risperidone (B) is a second-generation antipsychotic that does not have as high a risk of agranulocytosis or seizures compared to Clozapine. Chlorpromazine (D) is another first-generation antipsychotic that is not commonly associated with agranulocytosis or seizures at high doses.
Educationally, it is important to understand the side effect profiles of different antipsychotic medications to make informed treatment decisions. Clozapine is a highly effective medication for treatment-resistant schizophrenia, but its potential for severe side effects like agranulocytosis necessitates close monitoring and careful consideration before prescribing. This knowledge is crucial for healthcare professionals to provide safe and effective care to patients with psychiatric disorders.